share_log
Reuters ·  02:17
FDA Grants Accelerated Approval to Encorafenib With Cetuximab and Mfolfox6 for Metastatic Colorectal Cancer With a Braf V600E Mutation
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment